ERCAL Announces Changes in Leadership: Welcomes New President and Chairman of the Board
On the basis of a majority vote of the ERCAL Board of Directors, including Dr. Roberto Giugliani, Dr. Ignacio Zarante, Diego Gil Cardozo (President of FECOER), Maria Elena Almendariz (President of FEPER), and Richard Salvatierra (President of AHF), and with the abstention vote of Sylvia Hafez, the decision was taken to implement a change in ERCAL’s organizational leadership.
ERCAL is pleased to announce the appointment of Diego Gil Cardozo as the new Interim President. As current president of FECOER, and with vast experience in the Rare Disease landscape of Latin America, Diego brings a strong commitment to ERCAL’s mission. His leadership will be instrumental in guiding ERCAL forward. We are also delighted to announce the appointment of Dr. Roberto Giugliani as Chairman of the Board of ERCAL. Both of these appointments have also been voted on by a majority of ERCAL’s Board of Directors, cited above.
We express our gratitude to both Diego Gil Cardozo and Dr. Roberto Giugliani for stepping into their new roles and their commitment to advancing ERCAL’s mission. We are confident that under their leadership, ERCAL will continue to make strides in addressing the challenges faced by individuals with rare diseases in the region.
Additionally, we are pleased that these leadership changes are also supported by the 10 Latin American patient advocacy organizations that have been working and will continue to work with us to advance ERCAL’s mission and vision.
Enfermedades Raras en el Caribe y América Latina (ERCAL) is an initiative born from the need for regional policy and action plans for rare diseases. ERCAL aims to bridge the gap in rare diseases in Latin America and the Caribbean (LAC) by working closely with local patient advocacy groups, the region’s leading researchers and physicians, medical societies, and non-governmental organizations committed to improving care for rare diseases. Our mission is to engage stakeholders to collaborate in bridging the gaps in rare diseases and raise awareness in the LAC region.